24-HOUR CYCLOPHOSPHAMIDE INFUSION THERAPY FOR MALIGNANT MESOTHELIOMA OF THE PLEURA

被引：5
|
作者：
ANDERSON, H
HASLETON, P
MICHIE, AB
JOHNSON, RJ
THATCHER, N
机构：
[1] CHRISTIE HOSP & HOLT RADIUM INST,DEPT RADIOL,MANCHESTER M20 9BX,LANCS,ENGLAND
[2] WYTHENSHAWE HOSP,DEPT HISTOPATHOL,MANCHESTER M23 9LT,LANCS,ENGLAND
来源：
BRITISH JOURNAL OF DISEASES OF THE CHEST | 1988年 / 82卷 / 01期
关键词：
D O I：
10.1016/0007-0971(88)90009-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：64 / 69
页数：6
相关论文
共 50 条
  • [1] MALIGNANT MESOTHELIOMA OF THE PLEURA
    CHRETIEN, J
    REVUE FRANCAISE DES MALADIES RESPIRATOIRES, 1979, 7 (03): : 221 - 222
  • [2] MALIGNANT MESOTHELIOMA OF THE PLEURA
    TRAMUJAS, A
    ARTIGAS, GV
    DISEASES OF THE CHEST, 1957, 32 (03): : 340 - 343
  • [3] MALIGNANT MESOTHELIOMA OF THE PLEURA
    EISENSTADT, HB
    DISEASES OF THE CHEST, 1956, 30 (05): : 549 - 556
  • [4] MALIGNANT MESOTHELIOMA OF THE PLEURA
    PISANI, RJ
    COLBY, TV
    WILLIAMS, DE
    MAYO CLINIC PROCEEDINGS, 1988, 63 (12) : 1234 - 1244
  • [5] A 24-hour continuous infusion study of bivalirudin in the rat
    Gleason, TG
    Chengelis, CP
    Jackson, CB
    Lindstrom, P
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2003, 22 (03) : 195 - 206
  • [6] Pharmacokinetics of a 24-hour intravenous ketoprofen infusion in children
    Kokki, H
    Karvinen, M
    Jekunen, A
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2002, 46 (02) : 194 - 198
  • [7] AVOIDANCE OF RENAL TOXICITY BY 24-HOUR INFUSION OF CISPLATIN
    BOZZINO, JM
    PRASAD, V
    KORIECH, OM
    CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 351 - 352
  • [8] Clinical pharmacokinetics and pharmacodynamics of paclitaxel: A 3-hour infusion versus a 24-hour infusion
    Ohtsu, T
    Sasaki, Y
    Tamura, T
    Miyata, Y
    Nakanomyo, H
    Nishiwaki, Y
    Saijo, N
    CLINICAL CANCER RESEARCH, 1995, 1 (06) : 599 - 606
  • [9] THE TREATMENT OF MALIGNANT MESOTHELIOMA OF THE PLEURA
    KAUKEL, E
    KOSCHEL, G
    MEDIZINISCHE KLINIK, 1991, 86 (05) : 259 - 262
  • [10] Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results
    Holmes, FA
    Valero, V
    Walters, RS
    Theriault, RL
    Booser, DJ
    Gibbs, H
    Fraschini, G
    Buzdar, AU
    Willey, J
    Frye, D
    Asmar, L
    Hortobagyi, GN
    ANNALS OF ONCOLOGY, 1999, 10 (04) : 403 - 411
12345